HighTower Advisors’s Fortress Biotech FBIO Stock Holding History

HighTower Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,913	Closed	-$24K	–	3629
2023 Q2	$24K	Sell	2,913 -2,747	-49%	-$27.2K	﹤0.01%	3237
2023 Q1	$69K	Buy	5,660 +2,813	+99%	+$33.5K	﹤0.01%	3007
2022 Q4	$28K	Hold	2,847	–	–	﹤0.01%	3096
2022 Q3	$36K	Hold	2,847	–	–	﹤0.01%	2923
2022 Q2	$35K	Hold	2,847	–	–	﹤0.01%	2951
2022 Q1	$58K	Hold	2,847	–	–	﹤0.01%	3058
2021 Q4	$107K	Sell	2,847 -83	-3%	-$3.7K	﹤0.01%	2907
2021 Q3	$142K	Hold	2,930	–	–	﹤0.01%	2795
2021 Q2	$157K	Hold	2,930	–	–	﹤0.01%	2717
2021 Q1	$155K	Sell	2,930 -1,917	-40%	-$108K	﹤0.01%	2669
2020 Q4	$231K	Buy	4,847 +2,774	+134%	+$120K	﹤0.01%	2112
2020 Q3	$126K	Hold	2,073	–	–	﹤0.01%	2199
2020 Q2	$83K	Hold	2,073	–	–	﹤0.01%	2149
2020 Q1	$59K	Hold	2,073	–	–	﹤0.01%	1994
2019 Q4	$80K	Hold	2,073	–	–	﹤0.01%	2094
2019 Q3	$44K	Hold	2,073	–	–	﹤0.01%	2235
2019 Q2	$47K	Hold	2,073	–	–	﹤0.01%	2214
2019 Q1	$55K	Hold	2,073	–	–	﹤0.01%	2116
2018 Q4	$27K	Hold	2,073	–	–	﹤0.01%	2068
2018 Q3	$50K	Buy	+2,073	New	+$66.3K	﹤0.01%	2123

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighTower Advisors's FBIO Position: Q3 2023 in Review

HighTower Advisors sold out of Fortress Biotech (FBIO) in Q3 2023, closing a stake of 2,913 shares — an estimated $24K sold.

HighTower Advisors first reported a position in FBIO in Q3 2018 and held it in 20 quarters. The position peaked at $231K in Q4 2020. 48 funds tracked by Wall St. Rank hold FBIO as of Q3 2023.

HighTower Advisors reported no remaining Fortress Biotech position as of Q3 2023 after selling out during the quarter.
HighTower Advisors sold 2,913 Fortress Biotech shares in Q3 2023, an estimated $24K.
HighTower Advisors first reported a position in Fortress Biotech in Q3 2018 and held it in 20 quarters.
HighTower Advisors's Fortress Biotech position peaked at $231K in Q4 2020.
48 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2023.

Based on HighTower Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.